ArticleBreast cancer research and treatment2024

Impact of HER2 status on clinicopathological characteristics and pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer.

Yue Shi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.